Orchestra BioMed Holdings, Inc. Investment Income, Investment Expense
Orchestra BioMed Holdings, Inc. (OBIO) reported Investment Income, Investment Expense of $15.00 million for the 0-month period ending 2020-08-03, per its 10-K filed 2023-01-25.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInvestmentExpense · last filed 2023-01-25
- 2020-08-03: Investment Income, Investment Expense 0 month $15.00M.
| Period end | Investment Income, Investment Expense 0 month |
|---|---|
| 2020-08-03 | $15.00M 10-K · filed 2023-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |